Company intelligence / Profile preview

Aesop

Taipei, Taipei, Taiwanaesop.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

AESOP’s platforms have demonstrated high accuracy—DxPrime claims up to 99% accuracy in data identification and analysis. Medigator has been presented at major oncology conferences for its role in managing immune-related adverse events during immunotherapy, receiving notable attention from clinicians and industry partners.

Therapeutic areas: OtherImmunology
Modalities: AI-driven clinical decision supportData analytics
Industry: Digital Health Medical Devices

Partnerships

AstraZeneca Taiwan – collaboration on Medigator for precision medicine/immunotherapy AE managementSOAP Health – partnership to create Precision Patient Profiles by integrating conversational AI with DxPrime analytics for improved diagnosis and workflow efficiency

Beyond the preview

Go deeper on Aesop.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aesop.

Explore the full profile